社会经济贫困和脏移植结果
Lukas Ponette1,2, Karolien Wellekens1,2, Priyanka Koshy1,3
1Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven, Leuven, Belgium.
Kidney international reports
|January 8, 2026
概括
比利时的社会经济贫困与移植排斥有关,特别是T细胞介导排斥 (TCMR). 全民医疗保健可能会减轻一些负面影响,但对移植准入需要进一步研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 移植免疫学 移植免疫学
- 公共卫生 公共卫生
背景情况:
- 社会经济贫困是不良健康结果的已知决定因素,包括美国和英国的移植后死亡率和移植拒绝.
- 尽管英国有全民医疗,但差距仍然存在,这表明仅靠保险无法解决不平等问题.
- 社会经济贫困对比利时脏移植结果的影响仍未得到充分研究.
研究的目的:
- 调查比利时社会经济贫困和脏移植结果之间的联系.
- 评估剥夺对移植失败,死亡率和排斥事件的影响.
- 确定是否普遍医疗保健减轻了移植结果中的社会经济差异.
主要方法:
- 一项对1891名从2004年至2021年间在卢旺大学医院接受移植的接受者的队列研究.
- 用比利时多重贫困指数 (BIMD) 来评估社会经济贫困.
- 包括所有原因的移植失败,移植失败,死亡率和排斥在内的结果使用Cox和竞争风险模型进行了分析.
主要成果:
- 社会经济贫困与所有原因的移植失败 (HR: 1.07) 一致相关,但在调整后 (aHR: 1.03) 没有.
- 对于移植失败 (aHR: 1.04) 或死亡率 (aHR: 1.04) 没有发现显著的关联.
- 剥夺组的排斥风险显著不同 (P=0.030),主要是由于T细胞中介排斥 (TCMR) 的增加 (aHR:1.08),而抗体中介排斥 (AMR) 没有显示任何关联.
结论:
- 比利时的社会经济贫困与移植排斥有关,特别是TCMR,并且无可避免地与所有原因的移植失败有关.
- 缺乏与单独的移植失败或死亡率相关的证据.
- 结果表明,普遍医疗保健可能会减轻与社会经济剥夺有关的某些不良移植后结果,这需要进一步调查剥夺对移植获取的影响.
相关概念视频
01:28Kidney Transplant I: Introduction
333
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
333
01:26Kidney Transplant II: Surgical Procedure
298
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
298
01:16Kidney Transplant III: Nursing Management
307
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
307
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
256
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
256
01:24Chronic Kidney Disease II: Clinical Manifestations
543
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
543
01:29Acute Kidney Injury III: Clinical Manifestations
804
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
804